FIELD: chemistry.
SUBSTANCE: invention relates to novel 2-aza-bicyclo[3,1,0]hexane derivatives of formula (I), where A, B, n and R1 are defined in the description, and to use of such compounds or pharmaceutically acceptable salts of such compounds as medicinal agents, particularly as orexin receptor antagonists. The present invention also describes use of compounds of general formula (I) to produce a medicinal agent for preventing or treating insomnia.
EFFECT: improved method.
11 cl, 279 ex, 1 tbl, 10 dwg
Title | Year | Author | Number |
---|---|---|---|
2-AZA-BICYCLO[3,3,0]OCTANE DERIVATIVES | 2008 |
|
RU2478099C2 |
3-AZA-BICYCLO[3,3,0]OCTANE COMPOUNDS | 2008 |
|
RU2471796C2 |
AZETINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | 2007 |
|
RU2447070C2 |
PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
NEW DIAMIDES PYRIMIDIN-4,6 OF DICARBOXYLIC ACID FOR SELECTIVE INHIBITION OF COLLAGENASES | 2003 |
|
RU2344129C2 |
SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | 2009 |
|
RU2506257C2 |
TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS | 2020 |
|
RU2805595C1 |
PRODRUG OF FLUORINE-CONTAINING AMINO ACID | 2013 |
|
RU2639868C1 |
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
COMBINED THERAPY BASED ON CD20 ANTIBODY COMBINED WITH BCL-2 INHIBITOR AND MDM2 INHIBITOR | 2016 |
|
RU2727196C2 |
Authors
Dates
2012-09-10—Published
2007-12-28—Filed